Other News To Note
Thursday, October 6, 2011
Neurocrine Biosciences Inc., of San Diego, said it achieved its second milestone in a collaboration with Abbott, of Abbott Park, Ill., for elagolix and next-generation gonadotropin-releasing hormone receptor antagonists, triggering a $20 million payment.
Outside of the US
Part of Thomson Reuters
Note: our contact information has changed
In the U.S. and Canada: +1-800-336-4474
Outside the U.S.: +44-203-684-1796
Hours: Monday - Friday, 8:00am - 6:00 pm EST
© 2017 Thomson Reuters. Reproduction, reposting content is strictly prohibited.